N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-4-methoxy-2-(methyl(2-(methylthio)ethyl)amino)phenyl)acrylamide

ID: ALA4796376

PubChem CID: 162676308

Max Phase: Preclinical

Molecular Formula: C29H32N6O2S

Molecular Weight: 528.68

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C4CC4)c4ccccc34)n2)c(OC)cc1N(C)CCSC

Standard InChI:  InChI=1S/C29H32N6O2S/c1-5-28(36)31-23-16-24(27(37-3)17-26(23)34(2)14-15-38-4)33-29-30-13-12-22(32-29)21-18-35(19-10-11-19)25-9-7-6-8-20(21)25/h5-9,12-13,16-19H,1,10-11,14-15H2,2-4H3,(H,31,36)(H,30,32,33)

Standard InChI Key:  OZOUACMZTRKIJD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
   13.4401  -26.3205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4390  -27.1479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1537  -27.5608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8702  -27.1474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8674  -26.3169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1519  -25.9077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5814  -25.9037    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2911  -26.3178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0031  -25.9081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5736  -25.0801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1494  -28.3876    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.4327  -28.7962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7207  -27.5580    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.0082  -27.1422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0149  -26.3169    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3032  -25.9012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5858  -26.3103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5846  -27.1396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2968  -27.5516    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3072  -25.0745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9771  -24.5930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7263  -23.8071    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2147  -23.1422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6423  -24.5860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9047  -23.8047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3597  -23.1888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5523  -23.3531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2927  -24.1387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8394  -24.7512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7170  -26.3216    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   14.1547  -25.0814    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4416  -24.6665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4444  -23.8415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7258  -25.0766    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1603  -23.4314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9716  -22.8089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3067  -22.3205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4321  -25.9103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  7 10  1  0
  8  9  1  0
  3 11  1  0
 11 12  1  0
  2 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 20 21  2  0
 21 22  1  0
 22 25  1  0
 24 20  1  0
 16 20  1  0
 22 23  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
  9 30  1  0
  6 31  1  0
 31 32  1  0
 32 33  1  0
 32 34  2  0
 33 35  2  0
 36 23  1  0
 37 36  1  0
 23 37  1  0
 30 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4796376

    ---

Associated Targets(Human)

PC-9 (1037 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H292 (733 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 528.68Molecular Weight (Monoisotopic): 528.2307AlogP: 6.11#Rotatable Bonds: 11
Polar Surface Area: 84.31Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.65CX Basic pKa: 3.27CX LogP: 5.73CX LogD: 5.73
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.23Np Likeness Score: -1.07

References

1. Li J,An B,Song X,Zhang Q,Chen C,Wei S,Fan R,Li X,Zou Y.  (2021)  Design, synthesis and biological evaluation of novel 2,4-diaryl pyrimidine derivatives as selective EGFR inhibitors.,  212  [PMID:33429247] [10.1016/j.ejmech.2020.113019]

Source